120
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia

, , , , , , , & show all
Pages 307-324 | Published online: 18 Jan 2012

References

  • BarceloFOrtiz-LombardiaMMartorellMDNA-binding characteristics of mithramycin and chromomycin analogues obtained by combinatorial biosynthesisBiochemistry20104949105431055221067184
  • KollerCAMillerDMPreliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyureaN Engl J Med198631523143314382431313
  • YuanPWangLWeiDTherapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancerCancer2007110122682269017973266
  • RyutoMOnoMIzumiHInduction of vascular endothelial growth factor by tumor necrosis factor in human glioma cellsJ Biol Chem19962714528220282288910439
  • CampbellVWDavinDThomasSThe G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the C-MYC and C-HA-RAS genes in regenerating liverAm J Med Sci199430731671728160706
  • TagashiraMKitagawaTIsonishiSOkamotoAOchiaiKOhtakeYMithramycin represses MDR1 gene expression in vitro, modulating multidrug resistanceBiol Pharm Bull200023892692910963297
  • BianchiNOstiFRutiglianoCThe DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cellsBr J Haematol1999104225826510050705
  • FibachEBianchiNBorgattiMPrusEGambariRMithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cellsBlood200310241276128112738678
  • GambariRFibachEMedicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemiaCurr Med Chem20071419921217266579
  • KingPDPerryMCHepatotoxicity of chemotherapyOncologist200161216217611306728
  • FundueanuGNastruzziCCarpovADesbrieresJRinaudoMPhysico- chemical characterization of Ca-alginate microparticles produced with different methodsBiomaterials199920151427143510454015
  • NastruzziCCortesiREspositoELiposomes as carriers for DNA-PNA hybridsJ Control Release200068223724910925132
  • KedarUPhutanePShidhayeSKadamVAdvances in polymeric micelles for drug delivery and tumor targetingNanomedicine20106671472920542144
  • NishiyamaNKataokaKCurrent state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene deliveryPharmacol Ther2006112363064816815554
  • BaeYNishiyamaNFukushimaSKoyamaHYasuhiroMKataokaKPreparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacyBioconjug Chem200516112213015656583
  • VonarbourgAPassiraniCSaulnierPBenoitJPParameters influencing the stealthiness of colloidal drug delivery systemsBiomaterials200627244356437316650890
  • LetchfordKBurtHA review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomesEur J Pharm Biopharm200765325926917196803
  • ParkYJLeeJYChangYSRadioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imagingBiomaterials200223387387911771706
  • HaradaYYamamotoTSakaiMEffects of organic solvents on drug incorporation into polymeric carriers and morphological analyses of drug-incorporated polymeric micellesInt J Pharm20114041–227128021093556
  • MikhailASAllenCBlock copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levelsJ Control Release2009138321422319376167
  • GaucherGMarchessaultRHLerouxJCPolyester-based micelles and nanoparticles for the parenteral delivery of taxanesJ Control Release2010143121219925835
  • BarraudLMerlePSomaEIncrease of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJ Hepatol200542573674315826724
  • PeerDKarpJHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
  • DansonSFerryDAlakhovVPhase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancerBr J Cancer200490112085209115150584
  • MatsumuraYPreclinical and clinical studies of anticancer drug- incorporated polymeric micellesJ Drug Target2007157–850751717671897
  • Cohen-SelaETeitlboimSChornyMSingle and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivityJ Pharm Sci20099841452146218704956
  • BrombergLTemchenkoMSolubilization of hydrophobic compounds by micellar solutions of hydrophobically modified polyelectrolytesLangmuir1999152586278632
  • GaucherGDufresneMHSantVPKangNMaysingerDLerouxJCBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Control Release20051091–316918816289422
  • GaucherGSatturwarPJonesMCFurtosALerouxJCPolymeric micelles for oral drug deliveryEur J Pharm Biopharm201076214715820600891
  • KarnikRGuFBastoPMicrofluidic platform for controlled synthesis of polymeric nanoparticlesNano Lett2008892906291218656990
  • AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
  • JahnAStavisSMHongJSVreelandWNDeVoeDLGaitanMMicrofluidic mixing and the formation of nanoscale lipid vesiclesACS Nano2010442077208720356060
  • CroySRKwonGSThe effects of Pluronic block copolymers on the aggregation state of nystatinJ Control Release200495216117114980765
  • MazzitelliSCaprettoLCarugoDZhangXPivaRNastruzziCOptimised production of multifunctional microfibres by microfluidic chip technology for tissue engineering applicationsLab Chip201111101776178521472178
  • ZhangXJonesPHaswellSJAttachment and detachment of living cells on modified microchannel surfaces in a microfluidic-based labon- a-chip systemChem Eng J2008135Suppl 1S8288
  • JohnsonBKFlash nanoprecipitation of organic actives via confined micromixing and block copolymer stabilizationPhD thesisPrinceton, NJPrinceton University2003
  • TosiAMazzitelliSCaprettoLGuerrieriRNastruzziCOptimization of lipospheres production by factorial design and their performances on a dielectrophoretic lab-on-a-chip platformColloids Surf A Physicochem Eng Asp200934017785
  • BohmerRMCampbellTABianchiDWSelectively increased growth of fetal haemoglobin-expressing adult erythroid progenitors after brief treatment of early progenitors with transforming growth factor betaBlood20009592967297410779447
  • RapoportNPhysical stimuli-responsive polymeric micelles for anticancer drug deliveryProg Polym Sci2007328–9962990
  • JohnsonBKPrud’hommeRKMechanism for rapid self-assembly of block copolymer nanoparticlesPhys Rev Lett2003911111830214525460
  • KabanovAVBatrakovaEVAlakhovVYPluronic block copolymers as novel polymer therapeutics for drug and gene deliveryJ Control Release2002822–318921212175737
  • FreyDDEngelhardtFGreitzerEMA role for “one-factor-at-a-time” experimentation in parameter designRes Eng Des20031426574
  • FreyDDWangHAdaptive one-factor-at-a-time experimentation and expected value of improvementTechnometrics2006483418431
  • CaprettoLCarugoDChengWHillMZhangXContinuous-flow production of polymeric micelles in microreactors: experimental and computational analysisJ Colloid Interface Sci2011357124325121353232
  • SezginZYükselNBaykaraTPreparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugsEur J Pharm Biopharm200664326126816884896
  • ChoucairAEisenbergAInterfacial solubilization of model amphiphilic molecules in block copolymer micellesJ Am Chem Soc200312539119931200014505421
  • ElhasiSAstanehRLavasanifarASolubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micellesEur J Pharm Biopharm200765340641317291732
  • AllenCMaysingerDEisenbergANano-engineering block copolymer aggregates for drug deliveryColloids Surf B Biointerfaces1999161–4327
  • LiSDHuangLPharmacokinetics and biodistribution of nanoparticlesMol Pharm20085449650418611037
  • BrombergLPolymeric micelles in oral chemotherapyJ Control Release200812829911218325619
  • MoghimiSMHunterACMurrayJCLong-circulating and target-specific nanoparticles: theory to practicePharmacol Rev200153228331811356986
  • KwonGSPolymeric micelles for delivery of poorly water-soluble compoundsCrit Rev Drug Ther Drug Carrier Syst2003205357403
  • BaeYDieziTAZhaoAKwonGSMixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agentsJ Control Release2007122332433017669540
  • FordisCMAnagnouNPDeanANienhuisAWSchechterANA beta-globin gene, inactive in the K562 leukemic cell, functions normally in a heterologous expression systemProc Natl Acad Sci U S A19848114448544896205398
  • RemsingLLGonzálezAMNur-e-AlamMMithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesisJ Am Chem Soc2003125195745575312733914
  • BaigIPerezMBranaAFMithramycin analogues generated by combinatorial biosynthesis show improved bioactivityJ Nat Prod200871219920718197601
  • McConnellSCHuoYLiuSRyanTMHuman globin knock-in mice complete fetal-to-adult hemoglobin switching in postnatal developmentMol Cell Biol201131487688321173165
  • JamsaiDZaibakFVadolasJA humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemiaGenomics200688330931516631345
  • ChakrabortyHDeviPGSarkarMDasguptaDMultiple functions of generic drugs: future perspectives of aureolic acid group of anti-cancer antibiotics and non-steroidal anti-inflammatory drugsMini Rev Med Chem20088433134918473925
  • BianchiNZuccatoCLamprontiIBorgattiMGambariRExpression of miR-210 during erythroid differentiation and induction of gamma-globin gene expressionBMB Rep200942849349919712585